… genomics and comparative genomics approach for identification and characterization of
potential drug targets in multi-drug resistant … baumannii has emerged as a therapeutic challenge…

… In addition, comparative genomics can be limited because genetic changes may have
different … Despite these challenges, comparative genomics has proven to be a valuable tool for …

… Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that can cause serious
problems … Analyses of closely related bacteriophages was carried out by comparing amino …

… such as Pseudomonas aeruginosa is a major clinical challenge. Rapid molecular diagnostics
(RMDs) have the potential to inform selection of empiric therapy in patients infected by P. …

… aeruginosa are notably challenging because of its high resistance to several classes of
antimicrobial agents; therefore, early diagnosis and control of infections have become vitally …

… One key challenge in this area is to understand how host … genome and all of the other
isolates. C Root-to-tip regression comparing genetic divergence from the reference genome (ie, …

… one of the most challenging targets for antimicrobial therapy … BLAST results comparing the
blaVEB-1 gene from the P. … Prevalence of multi drug resistant Pseudomonas aeruginosa in …

… The growing prevalence and diversity of carbapenemase producers among carbapenem-resistant
Pseudomonas aeruginosa (CRPA) isolates warrants an expansion of detection …

… ); 21 (22.7%) were classified as extremely drug resistant (XDR). Highest resistance rate was
… and the production of β-lactamase is a challenge in the fight against infectious diseases, the …

… by carbapenem-resistant Pseudomonas aeruginosa is becoming a greater challenge. This
study aimed to identify the imipenem resistance mechanism in P. aeruginosa isolated from a …